Beneficient Granted Listing Extension by Nasdaq
Beneficient (NASDAQ: BENF) has received a conditional listing extension from the Nasdaq Hearings Panel. The company must meet two key requirements to maintain its listing: file delayed financial reports and demonstrate compliance with the $1.00 per share minimum bid price requirement.
The delayed reports include the Annual Report (Form 10-K) for FY2025 and Q2 2025 Quarterly Report (Form 10-Q). To address the bid price requirement, BENF plans to seek shareholder approval for a reverse stock split if necessary. The company expects to meet these conditions within the granted extension period.
Beneficient (NASDAQ: BENF) ha ricevuto una estensione condizionale di quotazione dall'Nasdaq Hearings Panel. L'azienda deve soddisfare due requisiti chiave per mantenere la quotazione: presentare rendiconti finanziari differiti e dimostrare conformità al requisito di prezzo minimo di offerta di $1,00 per azione.
I rendiconti differiti includono il Rapporto Annuale (Mod. 10-K) per l'anno fiscale 2025 e il Rapporto Trimestrale Q2 2025 (Mod. 10-Q). Per affrontare il requisito del prezzo di offerta, BENF intende chiedere l'approvazione degli azionisti per una scissione inversa se necessario. L'azienda prevede di soddisfare queste condizioni entro il periodo di estensione concesso.
Beneficient (NASDAQ: BENF) ha recibido una extensión condicional de listado por parte del Nasdaq Hearings Panel. La empresa debe cumplir dos requisitos clave para mantener su listado: presentar informes financieros diferidos y demostrar cumplimiento con el requisito de precio mínimo de oferta de $1.00 por acción.
Los informes diferidos incluyen el Informe Anual (Form. 10-K) para el año fiscal 2025 y el Informe Trimestral del Segundo Trimestre 2025 (Form. 10-Q). Para abordar el requisito de precio de oferta, BENF planea buscar la aprobación de los accionistas para una reversión de acciones si es necesario. La empresa espera cumplir estas condiciones dentro del periodo de extensión concedido.
Beneficient (NASDAQ: BENF)은 나스닥 청문 패널로부터 조건부 상장 연장을 받았다. 회사는 상장 유지를 위해 두 가지 핵심 요건을 충족해야 한다: 지연된 재무보고 제출 및 주당 $1.00의 최소 주가 요건 준수 입증.
지연된 보고서는 FY2025의 연차보고서(Form 10-K)와 2025년 2분기 분기보고서(Form 10-Q)를 포함한다. 주가 요건을 해결하기 위해 BENF는 필요 시 주주 승인을 받아 주식 분할를 추진할 계획이다. 회사는 부여된 연장 기간 내에 이 조건들을 충족할 것으로 예상한다.
Beneficient (NASDAQ: BENF) a reçu une extension conditionnelle de cotation de la part du Nasdaq Hearings Panel. L'entreprise doit satisfaire à deux exigences clés pour maintenir sa cotation : déposer des rapports financiers retardés et démontrer la conformité à l'exigence de cours d'offre minimum de 1,00 $ par action.
Les rapports retardés incluent le Rapport Annuel (Formulaire 10-K) pour l'exercice 2025 et le Rapport Trimestriel T2 2025 (Formulaire 10-Q). Pour répondre à l'exigence de cours, BENF prévoit de solliciter l'approbation des actionnaires pour une fusion inverse si nécessaire. La société s'attend à satisfaire ces conditions pendant la période prolongée accordée.
Beneficient (NASDAQ: BENF) hat eine bedingte LISTING-Verlängerung vom Nasdaq Hearings Panel erhalten. Das Unternehmen muss zwei zentrale Anforderungen erfüllen, um seine Börsennotierung zu behalten: verzögerte Finanzberichte einreichen und Nachweis der Einhaltung der Mindestkursanforderung von 1,00 USD pro Aktie.
Die verzögerten Berichte umfassen den Jahresbericht (Form 10-K) für das Geschäftsjahr 2025 und den Quartalsbericht Q2 2025 (Form 10-Q). Um die Kursanforderung zu erfüllen, plant BENF, ggf. eine Reverse-Split der Aktien zu beantragen und die Zustimmung der Aktionäre einzuholen. Das Unternehmen erwartet, diese Bedingungen innerhalb des gewährten Verlängerungszeitraums zu erfüllen.
Beneficient (NASDAQ: BENF) تلقّت تمديداً مشروطاً لإدراجها من قبل Nasdaq Hearings Panel. يجب على الشركة تلبية شرطين رئيسيين للحفاظ على إدراجها: تقديم تقارير مالية مؤجلة و إثبات الامتثال لمتطلب الحد الأدنى لسعر العرض البالغ 1.00 دولار للسهم.
تشمل التقارير المؤجلة التقرير السنوي (النموذج 10-K) للسنة المالية 2025 وتقارير الربع الثاني لعام 2025 (النموذج 10-Q). وللتعامل مع متطلب سعر العرض، تخطط BENF لطلب موافقة المساهمين على تقسيم عكسي للأسهم إذا لزم الأمر. تتوقع الشركة أن تلبي هذه الشروط خلال فترة التمديد الممنوحة.
Beneficient（纳斯达克股票代码 BENF）已从纳斯达克听证委员会获得有条件的上市延长期。公司必须满足两个关键要求以维持上市：提交延迟的财务报告 和 证明符合每股1.00美元的最低报价要求。
延迟报告包括2025财年的年度报告（Form 10-K）和2025年第二季度季度报告（Form 10-Q）。为解决价格要求，BENF计划在必要时寻求股东批准进行 股票分拆。公司预计在授予的延期期间内满足这些条件。
- Nasdaq granted listing extension, providing additional time to meet compliance requirements
- Company has clear plan to address bid price requirement through potential reverse stock split
- Company has failed to file required financial reports on time
- Stock trading below $1.00 minimum bid price requirement
- Potential reverse stock split may be necessary, which could impact share liquidity
DALLAS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that, by letter dated September 9, 2025, the Company was notified by The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) had granted the Company’s request for continued listing on Nasdaq, subject to the Company (i) evidencing compliance with Nasdaq’s periodic reporting requirement by filing its Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (together, the “Delayed Reports”), with the Securities and Exchange Commission (“SEC”), and (ii) demonstrating compliance with the
The Company continues to work diligently with its auditor to complete and file the Delayed Reports and expects to do so within the extension period granted by the Panel. Additionally, to the extent to Company has not regained compliance with the bid price requirement, the Company plans to seek stockholder approval to effect a reverse stock split of its common stock, which the Company anticipates will allow it to demonstrate compliance with the
About Beneficient
Beneficient (Nasdaq: BENF) – Ben, for short – is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors − mid-to-high net worth individuals, small-to-midsized institutions and General Partners seeking exit options, anchor commitments and valued-added services for their funds− with solutions that could help them unlock the value in their alternative assets. Ben’s AltQuote® tool provides customers with a range of potential exit options within minutes, while customers can log on to the AltAccess® portal to explore opportunities and receive proposals in a secure online environment.
Its subsidiary, Beneficient Fiduciary Financial, L.L.C., received its charter under the State of Kansas’ Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight by the Office of the State Bank Commissioner.
For more information, visit www.trustben.com or follow us on LinkedIn.
Contacts
Matt Kreps: 214-597-8200, mkreps@darrowir.com
Michael Wetherington: 214-284-1199, mwetherington@darrowir.com
Investor Relations: investors@beneficient.com
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the listing and trading of the Company’s securities on Nasdaq, the Company’s intention to request a hearing from the Nasdaq hearing panel and the Company’s intention to regain compliance with the Nasdaq Listing Rules. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on our management’s beliefs, as well as assumptions made by, and information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected.
Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, among others, our ability to timely demonstrate compliance with the periodic reporting requirement and the bid price requirement within the extension period granted by the Panel, our ability to cure any deficiencies in compliance with any other Nasdaq Listing Rules, our ability to obtain stockholder approval for a reverse stock split of the Company’s common stock, risks related to the substantial costs and diversion of management’s attention and resources due to these matters and the risks, uncertainties, and factors set forth under “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and its subsequently filed Quarterly Reports on Form 10-Q and the risks and uncertainties contained in the Company’s Current Reports on Form 8-K. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.
Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
FAQ
What conditions did Nasdaq set for Beneficient (BENF) to maintain its listing?
How does Beneficient (BENF) plan to address the minimum bid price requirement?
What reports are currently delayed for Beneficient (BENF)?
What happens if Beneficient (BENF) fails to meet Nasdaq's conditions?
